Advertisement
Screener

INSULET CORPORATION (PODD) ROI

INSULET CORP ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • INSULET CORP roi for the quarter ending 2023-06-30 was 3.22%, a 70.82% increase year-over-year.
  • INSULET CORP roi for the quarter ending 2023-03-31 was 0.03%, a 98.68% decline year-over-year.
  • INSULET CORP roi for the quarter ending 2022-12-31 was 0.24%, a 73.32% decline year-over-year.
  • INSULET CORP roi for the quarter ending 2022-09-30 was 0.92%, a change of 2.57% year-over-year.
  • INSULET CORP roi for fiscal 2022 was 0.24%, a 73.32% decline from fiscal 2021.
  • INSULET CORP roi for fiscal 2021 was 0.92%, a 124.47% increase from fiscal 2020.
  • INSULET CORP roi for fiscal 2020 was 0.41%, a 66.02% decline from fiscal 2019.
  • INSULET CORP roi for fiscal 2019 was 1.20%.
Available history
2012-06-30 to 2023-06-30
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2023-06-303.22%$62.9M$27.30M$1.95B
2023-03-310.03%$600,000.00$23.80M$1.9B
2022-12-310.24%$4.6M$17.00M$1.88B
2022-09-300.92%$16.8M-$5.20M$1.83B
2022-06-301.89%$34.6M-$35.00M$1.83B
2022-03-312.39%$44.6M$27.80M$1.86B
2021-12-310.92%$16.8M$29.20M$1.83B
2021-09-30-1.65%-$29.5M$12.60M$1.78B
2021-06-30-1.78%-$30.5M-$25.00M$1.72B
2021-03-310.54%$8.9M$0.00$1.65B
2020-12-310.41%$6.8M-$17.10M$1.66B
2019-12-311.20%$11.6M$5.00M$963.8M
2018-03-31-3.14%-$23.39M-$6.60M$743.9M
2017-12-31-3.70%-$26.8M-$6.86M$724.67M
2014-06-30-22.06%-$59.05M-$29.11M$267.63M
2013-12-31-18.88%-$44.97M-$2.50M$238.25M
2013-09-30-22.65%-$52.67M-$21.29M$232.54M
2013-06-30-17.73%-$43.8M-$10.52M$247.01M
2013-03-31-19.07%-$47.75M-$10.66M$250.47M
2012-12-31-31.95%-$51.87M-$10.19M$162.34M
2012-09-30-33.72%-$56.01M-$12.42M$166.1M
2012-06-30-33.17%-$57.16M-$14.48M$172.32M

Annual ROI

DateROINet income 12 monthDebt plus equity
2022-12-310.24%$4.6M$1.88B
2021-12-310.92%$16.8M$1.83B
2020-12-310.41%$6.8M$1.66B
2019-12-311.20%$11.6M$963.8M
2013-12-31-18.88%-$44.97M$238.25M
2012-12-31-31.95%-$51.87M$162.34M

Similar stocks

Stock NameCountryMarket CapPE Ratio
GLAUKOS Corp (GKOS)United States$9.135B-43.73
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Penumbra Inc (PEN)United States$12.596B77.33
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85